Biopharma News

Dec 01, 2017
By BioPharm International Editors
The company has opened a new California facility that, combined with its existing site in Foster City, CA, will quadruple its laboratory footprint for gene therapy products.
Nov 28, 2017
By BioPharm International Editors
The joint venture will focus on the discovery, development, and commercialization of potential new drugs for the global market as well as speed delivery of new medicines to China.
Nov 20, 2017
By BioPharm International Editors
The agency has approved a biologic-based new molecular entity for treating hemophilia A and has expanded the indication for a leukemia drug to now treat a common form of non-Hodgkin lymphoma.
Nov 20, 2017
By BioPharm International Editors
Ontruzant is the first biosimilar of Roche’s Herceptin (trastuzumab) to be approved in Europe.
Nov 20, 2017
By BioPharm International Editors
The opnME.com platform offers scientists access to best-in-class molecules supported by comprehensive data packages.
Nov 16, 2017
By BioPharm International Editors
As part of the deal, J&J’s Janssen will pay an upfront payment of $50 million to research, develop, and commercialize up to six bispecific antibodies.
Nov 16, 2017
By BioPharm International Editors
Bayer will make a $400-million upfront payment to develop and commercialize two anti-cancer compounds in Loxo Oncology’s portfolio.
Nov 16, 2017
By BioPharm International Editors
The entities announced that they will partner to improve access to cancer treatments and diagnostics in Ethiopia, Uganda, and Tanzania.
Nov 13, 2017
By BioPharm International Editors
The company has appointed Albert Bourla, PhD, as its new COO.
Nov 10, 2017
By BioPharm International Editors
The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.
native1_300x100
lorem ipsum